Cargando…
Casein Kinase 2 inhibition sensitizes medulloblastoma to temozolomide
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Since surviving patients experience severe neurocognitive disabilities, better and more effective treatments are needed to enhance their quality of life. Casein Kinase 2 (CK2) is known to regulate cell growth and survival in mu...
Autores principales: | Nitta, Ryan T., Bolin, Sara, Luo, Emily, Solow-Codero, David E., Samghabadi, Peyman, Purzner, Teresa, Aujla, Parvir S., Nwagbo, Ginikachi, Cho, Yoon-Jae, Li, Gordon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800621/ https://www.ncbi.nlm.nih.gov/pubmed/31406250 http://dx.doi.org/10.1038/s41388-019-0927-y |
Ejemplares similares
-
Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide
por: Nitta, Ryan T., et al.
Publicado: (2019) -
γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth
por: Bui, Timothy T, et al.
Publicado: (2015) -
Intracranial fat migration: A newly described complication of autologous fat repair of a cerebrospinal fluid leak following supracerebellar infratentorial approach
por: Ludwig, Cassie A., et al.
Publicado: (2014) -
Phosphodiesterase 4D acts downstream of Neuropilin to control Hedgehog signal transduction and the growth of medulloblastoma
por: Ge, Xuecai, et al.
Publicado: (2015) -
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours
por: von Bueren, A O, et al.
Publicado: (2012)